Could a simple ultrasound replace costly scans for liver cancer patients?
NCT ID NCT06261814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether contrast-enhanced ultrasound (CEUS) can accurately show how well liver tumors respond to a treatment called chemoembolization (TACE). Currently, doctors wait 1-2 months after TACE and use MRI or CT scans to check results. CEUS can be done during the procedure itself, potentially giving faster and cheaper answers. About 266 adults scheduled for TACE will receive CEUS, and researchers will compare its accuracy to standard imaging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple belly press make liver cancer radiation more precise?
- Can a Heat-and-Freeze treatment plus a vaccine outsmart pancreatic cancer?
- A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure
- Can a cancer vaccine prime the body to better fight liver tumors?
- A drug used during liver surgery may cut the risk of major complications — a study puts it to the test
- Engineered immune cells take aim at childhood liver cancers